Jingsong Liu

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Harbin Medical University(Current)

First Affiliated Hospital of Harbin Medical University

Shenzhen Institutes of Advanced Technology

Chinese Academy of Sciences

Chinese Center For Disease Control and Prevention

Jingsong Liu is an author at Harbin Medical University specializing in umbilical cord-derived mesenchymal stem cells, mesenchymal stromal cell exosomes, and exosome-based therapy.

ORCID

Publications per year

2024–2025

Publications

Exosomes derived from umbilical cord-mesenchymal stem cells inhibit the NF-κB/MAPK signaling pathway and reduce the inflammatory response to promote recovery from spinal cord injury

Zhiwei Luan, Jingsong Liu, Mi Li et al. · Journal of Orthopaedic Surgery and Research · 2024 · 29 citations · Full text

Medicine, Cell Biology, Neuroscience +17

Spatiotemporal Targeted Delivery of Biomimetic Bacterial Outer Membrane Nanoparticles for Enhanced Spinal Cord Injury Repair

Pengfei Li, Jingsong Liu, Mi Li et al. · Advanced Materials · 2025 · 20 citations

Pharmacy, Bioengineering, Pharmaceutics +17

3D Bioprinted Tissue‐Engineered Bone with Enhanced Mechanical Strength and Bioactivities: Accelerating Bone Defect Repair through Sequential Immunomodulatory Properties

D. Liu, Jingsong Liu, Pengcheng Zhao et al. · Advanced Healthcare Materials · 2024 · 17 citations

Engineering, Bioengineering, Biomedical Engineering +17

Nasal Delivery of Engineered Exosomes via a Thermo‐Sensitive Hydrogel Depot Reprograms Glial Cells for Spinal Cord Repair

Jingsong Liu, Pengfei Li, Zhibin Peng et al. · Advanced Science · 2025 · 12 citations · Full text

Engineering, Neurobiology, Neuroscience +17

1–4 of 4